[BAX] Baxter International Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 44.21 Change: 0.05 (0.11%)
Ext. hours: Change: 0 (0%)

chart BAX

Refresh chart

Strongest Trends Summary For BAX

BAX is in the medium-term up 12% in 3 months and up 26% in 1 year. In the long-term up 134% in 6 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney diseases, trauma, and other chronic and acute medical conditions. Its BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and certain vaccines. The company?s Medical Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics; products and services related to pharmacy compounding, drug formulation, and packaging technologies; and technologies and therapies for peritoneal dialysis, in-center and home hemodialysis, and continuous renal replacement

Fundamental Ratios
Shares Outstanding EPS1.04 EPS Growth - 4 Quarters-41.96% EPS Growth - Q/Q-77.94%
EPS Growth - Y/Y41.76% Sales Growth - 4 Quarters -13.81% Sales Growth - Q/Q-15.83% P/E55.7
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA9.54% ROE32.67% ROI12.64%
Current Ratio1.6 Quick Ratio1.03 Long Term Debt/Equity2.1 Debt Ratio0.84
Gross Margin48.63% Operating Margin15.2% Net Profit Margin14.29% Dividend Payout Ratio-46.86%
Dividend Yield
Fundamental Data
Cash From Financing Activities384 M Cash From Investing Activities-770 M Cash From Operating Activities96 M Gross Profit1.92 B
Net Profit332 M Operating Profit435 M Total Assets24.86 B Total Current Assets9.73 B
Total Current Liabilities6.07 B Total Debt10.01 B Total Liabilities17.6 B Total Revenue3.89 B
Technical Data
High 52 week81.54 Low 52 week61.23 Last close75.76 Last change-1.2%
RSI53.02 Average true range1.36 Beta0.58 Volume1.84 M
Simple moving average 20 days-0.28% Simple moving average 50 days-1.91% Simple moving average 200 days5.41%
Performance Data
Performance Week0.05% Performance Month2.14% Performance Quart3.44% Performance Half20.84%
Performance Year7.66% Performance Year-to-date15.4% Volatility daily0.84% Volatility weekly1.88%
Volatility monthly3.84% Volatility yearly13.31% Relative Volume171.45% Average Volume2.83 M
New High New Low

News

2019-08-21 11:05:03 | Tandem Diabetes Rides on t:slim X2 Uptake, Product Pipeline

2019-08-21 11:00:03 | FDA OKs Medtronic's Evolut TAVR New Indication for Low Risk

2019-08-21 09:10:01 | Here's Why You Should Hold on to McKesson MCK Stock Now

2019-08-21 08:54:12 | Here's Why You Should Add Stryker SYK to Your Portfolio

2019-08-21 08:39:12 | Restoration Robotics HAIR Wins CE Mark for ARTAS iX System

2019-08-21 08:30:00 | The Baxter International Foundation and Direct Relief Launch Program to Improve Diabetes Care in Underserved Communities

2019-08-20 10:00:02 | Medtronic MDT Beats on Q1 Earnings, Ups FY20 EPS Guidance

2019-08-20 09:30:01 | BAX vs. BSX: Which Stock Is the Better Value Option?

2019-08-20 09:01:01 | Here's Why You Should Hold Varian Medical VAR Stock Now

2019-08-20 08:15:12 | Walgreens WBA Expands Partnership With Retail Giant Kroger

2019-08-20 08:14:12 | Here's Why You Should Hold Onto IDEXX IDXX Stock for Now

2019-08-20 07:45:11 | Here's Why You Should Invest in DaVita DVA Stock For Now

2019-08-19 09:14:01 | Here's Why You Should Retain Nevro NVRO in Your Portfolio

2019-08-19 09:12:01 | Here's Why You Should Retain Wright Medical Stock For Now

2019-08-19 08:18:12 | Edwards Lifesciences' EW SAPIEN 3 TAVR Receives FDA Nod

2019-08-16 09:52:01 | Here's Why You Should Hold Onto Omnicell OMCL Stock for Now

2019-08-16 09:51:01 | QIAGEN Posts QIAstat-Dx Gastrointestinal Panel Study Results

2019-08-16 09:49:01 | Here's Why You Should Snap Up Baxter International BAX Now

2019-08-16 09:47:01 | Accuray ARAY Reports Loss in Q4, Revenues Beat Estimates

2019-08-16 09:18:01 | The Zacks Analyst Blog Highlights: Deere, Baxter, EPAM Systems, NiSource and Universal Display

2019-08-15 14:16:06 | Top Analyst Reports: Deere, Baxter & More

2019-08-15 09:13:01 | Baxter's PrisMax Adopted by Hamilton Health Care System

2019-08-15 08:34:00 | Baxter and COSMED Announce Partnership to Bring Next-generation Indirect Calorimetry Device, Q-NRG+, to Support Clinical Nutrition Globally

2019-08-14 16:15:00 | Baxter to Present at the Morgan Stanley 17th Annual Global Healthcare Conference

2019-08-14 12:14:04 | CVS Health Banks on Health Care Benefit Prospects Amid Woes

2019-08-14 09:40:01 | ResMed RMD Hits a New 52-Week High: What's Driving It?

2019-08-14 09:35:01 | Here's Why You Should Hold Onto Insulet PODD Stock for Now

2019-08-14 09:33:01 | Myriad Genetics MYGN Q4 Earnings Lag Estimates, Revenues Up

2019-08-14 08:38:12 | Zacks.com featured highlights include: Abbott Laboratories, Baxter International, First Horizon National, OUTFRONT Media and ICF International

2019-08-14 08:15:00 | 3 Healthcare Stocks at All-Time Highs: Are They Buys?

2019-08-13 16:15:00 | Baxter to Present at the 2019 Wells Fargo Healthcare Conference

2019-08-13 10:18:02 | Boston Scientific Rides on New Products Amid Dull Pacer Sales

2019-08-13 09:35:01 | Baxter BAX Hits 52-Week High, Can the Run Continue?

2019-08-13 09:10:01 | Canopy Growth Set to Acquire Beckley Canopy Therapeutics

2019-08-13 08:07:00 | Georgia-based Hamilton Health Care System First in U.S. to Use New Baxter Technology in the ICU

2019-08-13 07:05:11 | 5 Stocks Trading Near 52-Week High With More Room to Run

2019-08-12 07:40:11 | Glaukos GKOS Q2 Loss Wider Than Estimates, '19 View Raised

2019-08-09 09:45:01 | Nevro NVRO Q2 Loss Wider Than Expected, Revenues Down Y/Y

2019-08-09 09:33:01 | Inogen INGN Q2 Earnings Miss Estimates, 2019 View Lowered

2019-08-09 08:54:12 | Pacific Biosciences PACB Beats on Q2 Earnings & Revenues

2019-08-09 08:37:12 | Allscripts MDRX Q2 Earnings Top Estimates, Revenues Lag

2019-08-09 07:31:11 | Tandem TNDM Q2 Loss Narrower Than Expected, Sales Top Mark

2019-08-08 10:03:02 | BioScrip Closes Option Care Merger, Incurs Wider Q2 Loss

2019-08-08 09:11:01 | Cardinal Health CAH Q4 Earnings and Revenues Top Estimates

2019-08-08 09:10:01 | LHC Group LHCG Q2 Earnings Beat Estimates, Revenues Miss

2019-08-08 09:02:01 | Orthofix Medical OFIX Beats on Q2 Earnings, Margins Down

2019-08-08 08:59:12 | OPKO Health OPK Q2 Earnings and Revenues Beat Estimates

2019-08-08 08:22:12 | Wright Medical WMGI Earnings Beat in Q2, Guidance Slashed

2019-08-08 08:10:12 | Cardiovascular Systems CSII Earnings Match Estimates in Q4

2019-08-07 11:00:03 | CVS Health CVS Beats on Q2 Earnings, Raises '19 Guidance